Description
Advancing innovation through partnership
To develop the Euphora™ low-profile semicompliant balloon dilatation catheter, we partnered with nearly 2,000 interventional cardiologists and catheter lab professionals.1–5 The result is:
- Superior deliverability6
- Superb kissing balloons technique (KBT) performance7
- Lowest crossing profile compared to leading competitors8
TM* Third-party brands are trademarks of their respective owners.
- Based on balloon conjoint results. May 2010.
- Based on design study for next generation balloons. May 2010.
- Based on design freeze document 10131784DOC, Euphora™. October 2014.
- Based on customer needs, Euphora™. 2013.
- Based on various qualitative research, focus groups, surveys conducted at conventions and meetings. 2010, 2011, 2013 and 2014.
- Based on bench test data report 10169651DOC, Euphora™ RX balloon dilatation catheter versus Trek™*, Emerge™*, Sprinter™ Legend™ Ryujin* Plus balloons 2.50 x 15mm balloons tested. November 2014. Bench test data my not be indicative of clinical performance.
- Based on bench test data report 10169651DOC, 6F KBT testing. 3.75 mm and 4.00 mm Euphora™ RX balloon models are not suitable for simultaneous use within a 2 mm (6F/MGCID 1.8 mm [0.70"]) guide catheter. November 2014. Bench test data my not be indicative of clinical performance.
- Based on bench test data report 10169651DOC, Euphora™ RX balloon dilatation catheter versus Trek™* and Emerge™* balloons. 2.50 x 15mm balloons tested. Crossing profile is a measure of the distal balloon crossing profile. November 2014. Bench test date may not be indicative of clinical performance.
- Based on product label technical information chart (PLTIC) 10124692DOC, Euphora™. June 2017.
Not what you're looking for?
Find more information, including other available configurations, for Euphora™ semicompliant balloon dilatation catheter.